Bank of Montreal
REGN icon

Bank of Montreal’s Regeneron Pharmaceuticals REGN Stock Holding History

Bank of Montreal’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,900
Closed -$2.24M – 3986
2025
Q4 		$2.24M Hold
2,900
– – ﹤0.01% 1606
2025
Q3 		$1.63M Hold
2,900
– – ﹤0.01% 1744
2025
Q2 		$1.52M Buy
+2,900
New +$1.62M ﹤0.01% 1694
2022
Q2 		– Sell
-5,000
Closed -$3.48M – 4379
2022
Q1 		$3.48M Buy
+5,000
New +$3.16M ﹤0.01% 1642

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of Montreal's REGN Position: Q1 2026 in Review

Bank of Montreal reduced its Regeneron Pharmaceuticals (REGN) stake by 15% in Q1 2026, selling an estimated $11.8M and leaving 85,524 shares worth $66.1M. The position accounts for 0.02% of the portfolio, ranked #468.

Bank of Montreal first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $253M in Q4 2023. 1,396 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Bank of Montreal held 85,524 shares of Regeneron Pharmaceuticals worth $66.1M as of Q1 2026.
  • Bank of Montreal sold 15,453 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $11.8M.
  • Regeneron Pharmaceuticals made up 0.02% of Bank of Montreal's portfolio in Q1 2026, its #468 holding.
  • Bank of Montreal first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Regeneron Pharmaceuticals position peaked at $253M in Q4 2023.
  • 1,396 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.